BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6593228)

  • 1. Modulations of glycerophosphorylcholine and phosphorylcholine in Friend erythroleukemia cells upon in vitro-induced erythroid differentiation: a 31P NMR study.
    Carpinelli G; Podo F; Di Vito M; Proietti E; Gessani S; Belardelli F
    FEBS Lett; 1984 Oct; 176(1):88-92. PubMed ID: 6593228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
    Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
    Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid changes associated with erythroid differentiation of Friend erythroleukemia cells.
    Fallani A; Arcangeli A; Ruggieri S
    Toxicol Pathol; 1987; 15(2):170-7. PubMed ID: 3475757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of ether-linked glycerophospholipids in Friend erythroleukaemia cells differentiated by dimethyl sulphoxide or hexamethylenebisacetamide and in non-inducible clones treated with the inducers.
    Fallani A; Arcangeli A; Ruggieri S
    Biochem J; 1988 Oct; 255(2):731-5. PubMed ID: 3202842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-responsive element-binding protein mRNA levels during erythroid differentiation of murine erythroleukemia cells.
    Fuchs O
    Neoplasma; 1995; 42(4):179-85. PubMed ID: 7659183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of erythroid differentiation by cytoplast fusion in mouse erythroleukemia (Friend) cells.
    Watanabe T; Nomura S; Oishi M
    Exp Cell Res; 1985 Jul; 159(1):224-34. PubMed ID: 3861323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
    Tsiftsoglou AS; Sartorelli AC
    Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid characteristics of Friend erythroleukaemia cells differentiated by dimethyl sulphoxide or hexamethylenebisacetamide, and of non-inducible clones treated with the inducers.
    Fallani A; Arcangeli A; Ruggieri S
    Biochem J; 1988 Jun; 252(3):917-20. PubMed ID: 3421933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 5-methylcytosine removal from DNA of Friend erythroleukemia cells following exposure to several differentiating agents.
    Kuykendall JR; Cox R
    Cancer Lett; 1989 Sep; 47(1-2):149-52. PubMed ID: 2534571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroid differentiation and poly(ADP-ribose) synthesis in Friend leukemia cells.
    Morioka K; Tanaka K; Nokuo T; Ishizawa M; Ono T
    Gan; 1979 Feb; 70(1):37-46. PubMed ID: 156137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.
    Belardelli F; Proietti E; Ciolli V; Sestili P; Carpinelli G; Di Vito M; Ferretti A; Woodrow D; Boraschi D; Podo F
    Int J Cancer; 1989 Jul; 44(1):116-23. PubMed ID: 2787294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M
    J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR; Becker FF
    J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of membrane physical properties, biological response and insulin binding in Friend cells by low serum concentration.
    Simon I; Brown TJ; Ginsberg BH
    Biochim Biophys Acta; 1987 Jan; 896(2):165-72. PubMed ID: 3026472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in surface architecture during murine erythroleukemia cell differentiation as detected by lectin binding and agglutination.
    Sartorelli AC
    Biochim Biophys Acta; 1981 Nov; 649(1):105-12. PubMed ID: 6946835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E; Reuben RC; Rifkind RA; Marks PA
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of erythroleukemic cells in vitro: irreversible induction by dimethyl sulfoxide (DMSO).
    Preisler HD; Giladi M
    J Cell Physiol; 1975 Jun; 85(3):537-46. PubMed ID: 49357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early inhibition of phospholipid synthesis in dimethyl sulfoxide (DMSO) treated Friend erythroleukemia (FL) cells.
    Harel L; Lacour F; Friend C; Durbin P; Semmel M
    J Cell Physiol; 1979 Oct; 101(1):25-32. PubMed ID: 295286
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Friend cell erythrodifferentiation by modification of membrane phospholipid composition by choline analogues.
    Kaiho S; Mizuno K
    Biochim Biophys Acta; 1985 Jan; 838(1):175-8. PubMed ID: 3855361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal insulin binding and membrane physical properties of a Friend erythroleukemia clone resistant to dimethylsulfoxide-induced differentiation.
    Simon I; Brown TJ; Ginsberg BH
    Biochim Biophys Acta; 1984 Feb; 803(1-2):39-47. PubMed ID: 6365178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.